Cargando…

A Comparative Study of Hemorrhagic Conversion Patterns After Stroke Thrombolysis With Alteplase Versus Tenecteplase

Background and purpose: Tenecteplase is the thrombolytic drug of choice for acute ischemic stroke (AIS) as it has unique pharmacologic properties, along with results demonstrating its non-inferiority compared to alteplase. However, there are contradictory data concerning the risk of intracranial hem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ezzeldin, Mohamad, Hill, Courtney, Kerro, Ali, Percenti, Eryn, Delora, Adam, Santos, Juan, Saei, Hamzah, Greco, Lisa, Ezzeldin, Rime, El-Ghanem, Mohammad, Alderazi, Yazan, Kim, Yana, Poitevint, Cathleen, Mir, Osman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584357/ https://www.ncbi.nlm.nih.gov/pubmed/37859677 http://dx.doi.org/10.7759/cureus.46889

Ejemplares similares

A Rare Case of Cerebral Vasospasm Secondary to Primary Intraventricular Hemorrhage With an Immediate Improvement in Neurological Status Following Intra-arterial Therapy
por: Delora, Adam, et al.
Publicado: (2022)

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022)

Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
por: Yang, Nan, et al.
Publicado: (2023)

Replacing Alteplase with Tenecteplase: Is the Time Ripe?
por: Singh, Nishita, et al.
Publicado: (2023)

Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?
por: Mahmood, Ammad, et al.
Publicado: (2022)

Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study
por: Dhar, Nikita, et al.
Publicado: (2022)

Ultra-Short-Term Dual Antiplatelet Therapy in Treating Unruptured Brain Aneurysm With the Pipeline Flex-Shield Embolization Device
por: Delora, Adam, et al.
Publicado: (2022)

Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials
por: Xu, Na, et al.
Publicado: (2018)

Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke
por: Nguyen, Chi Phuong, et al.
Publicado: (2023)

Impact of poly-arginine peptides R18D and R18 on alteplase and tenecteplase thrombolysis in vitro, and neuroprotective stability to proteolysis
por: Meloni, Bruno P., et al.
Publicado: (2022)

Tenecteplase Thrombolysis in Posterior Circulation Stroke
por: Alemseged, Fana, et al.
Publicado: (2021)

Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review
por: Potla, Neha, et al.
Publicado: (2022)

Is Tenecteplase a Viable Alternative to Alteplase in the Treatment of Acute Ischemic Stroke?
por: Vaishnav, Anand Girish
Publicado: (2022)

Switching to Tenecteplase from Alteplase for Ischemic Stroke: Is it the Time for Universal Adoption?
por: Kharel, Sanjeev, et al.
Publicado: (2022)

The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke
por: Logallo, Nicola, et al.
Publicado: (2014)

Recanalization before Thrombectomy in Tenecteplase vs. Alteplase-Treated Drip-and-Ship Patients
por: Seners, Pierre, et al.
Publicado: (2019)

Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
por: Dong, Yi, et al.
Publicado: (2021)

Biosimilar Tenecteplase Versus Alteplase in Acute Ischemic Stroke: A Real World Study
por: Mohan, Ayush, et al.
Publicado: (2023)

Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit—TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit
por: Bivard, Andrew, et al.
Publicado: (2022)

Re: Tenecteplase for thrombolysis in stroke patients: Systematic review with meta-analysis
por: Bahadori, Maryam, et al.
Publicado: (2022)

Uric acid enhances alteplase-mediated thrombolysis as an antioxidant
por: Kikuchi, Kiyoshi, et al.
Publicado: (2018)

Intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction
por: Gao, Lilin, et al.
Publicado: (2022)

Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis
por: Fanikos, John, et al.
Publicado: (2021)

Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials
por: Kobeissi, Hassan, et al.
Publicado: (2023)

Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Shen, Ziyi, et al.
Publicado: (2023)

Thrombolysis for acute ischemic stroke by tenecteplase in the emergency department of a Moroccan hospital
por: Belkouch, Ahmed, et al.
Publicado: (2015)

Acute Ischemic Stroke Thrombolysis with Tenecteplase: An Institutional Experience from South India
por: Owais, Mohammed, et al.
Publicado: (2018)

Successful thrombolysis of left subclavian arterial thrombosis with intravenous bolus dose of tenecteplase
por: Akkala, Raghavender, et al.
Publicado: (2017)

Safety and efficacy of tenecteplase versus alteplase in acute coronary syndrome: a systematic review and meta-analysis of randomized trials
por: Guillermin, Alexandre, et al.
Publicado: (2016)

Tenecteplase versus Alteplase for the Management of Acute Ischemic Stroke in a Low-income Country–Nepal: Cost, Efficacy, and Safety
por: Nepal, Gaurav, et al.
Publicado: (2018)

Real-world comparative safety and efficacy of tenecteplase versus alteplase in acute ischemic stroke patients with large vessel occlusion
por: Psychogios, Klearchos, et al.
Publicado: (2021)

Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window
por: Pan, Yuanmei, et al.
Publicado: (2021)

Effect of Apixaban Pretreatment on Alteplase-Induced Thrombolysis: An In Vitro Study
por: Thalerová, Sandra, et al.
Publicado: (2021)

Erratum: Acute Ischemic Stroke Thrombolysis with Tenecteplase: An Institutional Experience from South India
Publicado: (2018)

Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study
por: Teivane, Agnete, et al.
Publicado: (2022)

Risk Factors for Early Intracerebral Hemorrhage after Intravenous Thrombolysis with Alteplase
por: Lin, Xianda, et al.
Publicado: (2020)

Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset
por: Kate, Mahesh, et al.
Publicado: (2018)

Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset
por: Kate, Mahesh, et al.
Publicado: (2018)

Ultra-Early Remote Intracranial Hemorrhage Complicating Intravenous Thrombolysis with Tenecteplase for Acute Ischemic Stroke
por: Kargiotis, Odysseas, et al.
Publicado: (2020)

Edaravone, a Synthetic Free Radical Scavenger, Enhances Alteplase-Mediated Thrombolysis
por: Kikuchi, Kiyoshi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ff6oohkvn487g4uraqv4pp71ov